Process for the synthesis and crystalline form of agomelatine
US7250531B2 · kind B2 · utility
6Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2005 |
| Grant date | Jul 31, 2007 |
| Priority date | — |
| Expiry date | May 23, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E10/72
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A process for the industrial synthesis and a new crystalline form of the compound of formula (I):Medicinal products containing the same which are useful in treating disorders of the melatoninergic system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.